(Total Views: 429)
Posted On: 12/04/2019 2:50:45 PM
Post# of 76
$SNGX News Article - NetworkNewsBreaks - Soligenix, Inc. (NASDAQ: SNGX) Completes Enrollment in Pivotal Phase 3 SGX301 Clinical Trial in Treatment of Cutaneous T-cell Lymphoma https://marketwirenews.com/news-releases/netw...31401.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
